GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » 10x Genomics Inc (STU:1KJ) » Definitions » Marketable Securities

10x Genomics (STU:1KJ) Marketable Securities : €47.1 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is 10x Genomics Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. 10x Genomics's Marketable Securities for the quarter that ended in Dec. 2024 was €47.1 Mil.

10x Genomics's annual Marketable Securities declined from Dec. 2022 (€198.5 Mil) to Dec. 2023 (€27.0 Mil) but then increased from Dec. 2023 (€27.0 Mil) to Dec. 2024 (€47.1 Mil).


10x Genomics Marketable Securities Historical Data

The historical data trend for 10x Genomics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

10x Genomics Marketable Securities Chart

10x Genomics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Marketable Securities
Get a 7-Day Free Trial - - 198.47 26.97 47.12

10x Genomics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.97 14.75 0.25 - 47.12

10x Genomics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


10x Genomics  (STU:1KJ) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


10x Genomics Marketable Securities Related Terms

Thank you for viewing the detailed overview of 10x Genomics's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


10x Genomics Business Description

Traded in Other Exchanges
Address
6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

10x Genomics Headlines

No Headlines